Detalhe da pesquisa
1.
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.
Nature
; 501(7466): 232-6, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23934108
2.
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Nature
; 471(7336): 110-4, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21368834
3.
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Nature
; 464(7287): 431-5, 2010 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20130576
4.
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity.
Proc Natl Acad Sci U S A
; 109(14): 5299-304, 2012 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22431598
5.
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.
Blood
; 119(24): 5807-16, 2012 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22538851
6.
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes.
Proc Natl Acad Sci U S A
; 107(50): 21248-55, 2010 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21081700
7.
Cell segmentation in images without structural fluorescent labels.
Biol Imaging
; 3: e16, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510169
8.
Live-cell microscopy reveals small molecule inhibitor effects on MAPK pathway dynamics.
PLoS One
; 6(8): e22607, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21829637
9.
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
Cancer Res
; 69(21): 8395-402, 2009 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19843851